Your browser doesn't support javascript.
loading
Two autopsy cases of sudden unexpected death from Dravet syndrome with novel de novo SCN1A variants.
Hata, Yukiko; Oku, Yuko; Taneichi, Hiromichi; Tanaka, Tomomi; Igarashi, Noboru; Niida, Yo; Nishida, Naoki.
Affiliation
  • Hata Y; Department of Legal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan.
  • Oku Y; Department of Legal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan.
  • Taneichi H; Department of Pediatrics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan.
  • Tanaka T; Department of Pediatrics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan.
  • Igarashi N; Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.
  • Niida Y; Division of Genomic Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Japan.
  • Nishida N; Department of Legal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan. Electronic address: nishida@med.u-toyama.ac.jp.
Brain Dev ; 42(2): 171-178, 2020 Feb.
Article in En | MEDLINE | ID: mdl-31677916
ABSTRACT

AIM:

Dravet syndrome (DS) is characterized by high epilepsy-related premature mortality with a markedly young age at death, however, autopsy report of sudden unexpected death with DS has been fewer than expected.

METHODS:

We report two autopsy cases with sudden unexpected death from DS. Case 1 was a 13-year-old male who drowned in a bathtub, and Case 2 was a 3-year-old female who died while sleeping. In Case 1, the blood concentration of the anticonvulsant, valproic acid, was below the recommended therapeutic range. Neuropathological investigation and genetic analysis of 402 cardiovascular disease-related and 146 epilepsy-related genes by next generation sequencing were applied.

RESULTS:

No significant neuronal loss with gliosis was observed in the brain of either patient. Although possible mild malformations of cortical development were found in both, the degree thereof was similar to that of age-matched controls. Genetic analysis identified a novel variant in SCN1A intron 23 (c.4477-3T > C) in Case 1 that falls outside of the minor splicing consensus sequence. In vitro splicing functional assays with minigene constructs revealed that this intronic variant leads to a 2-bp insertion immediately before exon 24 that results in protein truncation. Similarly, a novel de novo missense mutation of unknown significance, SCN1A_Arg187Pro, was identified in Case 2. In both cases, we also identified cardiomyopathy-related variants classified as likely pathogenic; however, the effect of these variants at death was minimal because there was an absence of pathological change indicating inherited cardiomyopathy.

CONCLUSION:

The present cases emphasize the need for multifaceted examination of DS cases so as to obtain a definitive autopsy diagnosis and to explore the mechanism of sudden unexpected death.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epilepsies, Myoclonic / NAV1.1 Voltage-Gated Sodium Channel Type of study: Prognostic_studies Limits: Adolescent / Child, preschool / Female / Humans / Male Language: En Journal: Brain Dev Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epilepsies, Myoclonic / NAV1.1 Voltage-Gated Sodium Channel Type of study: Prognostic_studies Limits: Adolescent / Child, preschool / Female / Humans / Male Language: En Journal: Brain Dev Year: 2020 Document type: Article Affiliation country: